{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:54Z","timestamp":1791357114800,"version":"4.3.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jcp.0b013e3181dd3103","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T04:28:32Z","timestamp":1273033712000},"page":"235-244","source":"Crossref","is-referenced-by-count":142,"title":["A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia"],"prefix":"10.1097","volume":"30","author":[{"given":"Gahan J.","family":"Pandina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Lindenmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Herben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kusumakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(95)91325-4","article-title":"Symptoms, signs, and diagnosis of schizophrenia.","volume":"346","author":"Andreasen","year":"1995","journal-title":"Lancet"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4088\/JCP.v64n1105","article-title":"Partial compliance and patient consequences in schizophrenia: our patients can do better.","volume":"64","author":"Keith","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"suppl 12","key":"R3-4-20210128","first-page":"5","article-title":"The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.","volume":"64","author":"Kane","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0447.2006.00982.x","article-title":"The case for long-acting antipsychotic agents in the post-CATIE era.","volume":"115","author":"Nasrallah","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2007.03.003","article-title":"Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.","volume":"93","author":"Davidson","year":"2007","journal-title":"Schizophr Res"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.09.012","article-title":"Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial.","volume":"90","author":"Kane","year":"2007","journal-title":"Schizophr Res"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopsych.2007.01.017","article-title":"Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.","volume":"62","author":"Marder","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R8-4-20210128","first-page":"1S","article-title":"Paliperidone palmitate, an atypical injectable antipsychotic, in prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.","volume":"63","author":"Hough","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pnpbp.2009.05.014","article-title":"Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia.","volume":"33","author":"Hough","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1600-0447.2000.101004323.x","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning.","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"R15-4-20210128","first-page":"216","article-title":"Initiation dosing of deltoid intramuscular paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on modeling and simulation.","volume":"22","author":"Samtani","year":"2009","journal-title":"J Pharm Pract"},{"key":"R16-4-20210128","first-page":"S31","article-title":"Assessment of the dose proportionality of paliperidone palmitate 25, 50, 100 and 150 mg eq., a new long-acting injectable antipsychotic following administration in the deltoid or gluteal muscles.","volume":"83","author":"Cleton","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.schres.2008.04.037","article-title":"Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.","volume":"104","author":"Juckel","year":"2008","journal-title":"Schizophr Res"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s11136-008-9400-z","article-title":"Psychometric properties of the Personal and Social Performance Scale (PSP) among individuals with schizophrenia living in the community.","volume":"17","author":"Kawata","year":"2008","journal-title":"Qual Life Res"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/YIC.0b013e3281c55f4f","article-title":"A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.","volume":"22","author":"Luthringer","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.","volume":"160","author":"Kane","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/schbul\/sbm033","article-title":"Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone.","volume":"33","author":"Olfson","year":"2007","journal-title":"Schizophr Bull"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.","volume":"58","author":"Marder","year":"1997","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:53Z","timestamp":1786040273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181dd3103","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}